\n<\/p>\n
Danone\u2019s striking \u20ac1bn ($1.15bn) (so it\u2019s said) swoop for Huel has come at something of a premium but underlines the skill with which the UK business built its brand, the corporate desire to tap into consumers\u2019 growing interest in protein \u2013 and with the rise of GLP-1 drugs providing an intriguing backdrop.<\/p>\n
Industry watchers see the French giant\u2019s move for the meal-replacement firm as part of the Activia maker\u2019s strategy to expand in protein-centric product areas and \u2018functional\u2019 nutrition, as well as an attempt to benefit from Huel’s experience in the direct-to-consumer channel.<\/p>\n
The deal \u2013 despite Danone not publicly confirming the price tag \u2013 has led to praise for Huel\u2019s founders and the company\u2019s present management team. And, amid the murmurings about whether consumer appetite for protein may be starting to plateau, the transaction confirms that the ingredient is a central factor in M&A in the sector.<\/p>\n
Set up in 2014 by entrepreneur Julian Hearn and former NHS dietician James Collier, Huel \u2013 a portmanteau of human fuel \u2013 sells its plant-based, protein-packed products in the UK, continental Europe and the US.<\/p>\n
The company started out as a direct-to-consumer business but now also markets its products \u2013 which contain 20-40g of plant-based protein (from a mix of peas, faba beans and rice) per serving \u2013 through bricks-and-mortar retail outlets.<\/p>\n
Huel, which employs around 350 staff, has a manufacturing site and warehouse in the English city of Milton Keynes. Its product range encompasses the flagship \u201cready-to-drink meals\u201d, as well as hot meals, bars and greens drinks.<\/p>\n
\u201cIn our view, Danone\u2019s acquisition of Huel looks strategically sensible and continues the group\u2019s push into higher-growth, health-led nutrition,\u201d Barclays analyst Warren Ackerman says.<\/p>\n
Danone\u2019s recent M&A has been peppered with deals for businesses focused more squarely on health, including last year\u2019s deal for a majority stake in Kate Farms, a US business that supplies\u00a0a range of products from nutritional shakes on sale at mass-market retailers to tube-feeding products sold directly to healthcare providers. Not all of Danone\u2019s attempts at M&A have succeeded. US kefir maker Lifeway Foods \u2013 of which Danone owns a minority stake \u2013 remains (for now) resolutely publicly listed.<\/p>\n
However, Danone\u2019s eye-catching move for Huel adds something different to the Actimel and Alpro maker\u2019s portfolio.<\/p>\n
“Huel adds something slightly different;\u00a0a scaled consumer brand in everyday complete nutrition, with strong digital execution and a younger, more lifestyle\u200b-\u200boriented consumer proposition. In that sense, Huel can sit between Danone\u2019s mainstream high\u200b-\u200bprotein offer and its more clinical nutrition assets and we therefore see this as a very strong addition to the portfolio,” Ackerman says.<\/p>\n<\/p><\/div>\n
The transaction also brings a profitable, consumer-facing business that\u2019s been growing at solid double-digits in recent years.<\/p>\n
The most recent set of Huel accounts available at Companies House, the UK business register, show the firm\u2019s revenue stood at \u00a3214m ($284.2m) for the 12 months to 31 July 2024, up 16% on a year earlier.<\/p>\n
Pre-tax profits almost trebled to \u00a313.8m. Huel recorded an adjusted EBITDA of \u00a318.2m, up 86% on the 12 months to the end of July 2023. Its profit for the year was \u00a313.1m, versus \u00a32.2m in the previous 12 months.<\/p>\n
\u201cIts circa 59% gross margin is strong, driven by premium pricing, a direct-to-consumer model and efficient powder-based manufacturing. The growing US presence is also notable, with the market now accounting for 31% of the total business,\u201d Stefano Di Napoli, the founder of the UK-based Consumer Products Growth Strategy consultancy, says.<\/p>\n
Di Napoli also points to the make-up of Huel\u2019s customer base. \u201cDanone\u2019s core consumers skew toward families and older adults, while Huel targets 25- to 45-year-olds, digitally native, health-conscious consumers. This is a segment Danone currently under-penetrates. An acquisition would provide immediate access to this audience and create opportunities for cross-selling and long-term brand expansion.\u201d<\/p>\n
But, away from who<\/em> buys Huel\u2019s products, it\u2019s how<\/em> they\u2019re bought that several observers have highlighted as they\u2019ve digested the deal. Huel has expanded from its direct-to-consumer roots, securing listings with UK grocers like Tesco and Sainsbury\u2019s, European retailers like Rewe and ICA and US customers like Target. However, DTC remains central to Huel\u2019s model and is seen as a principal reason why Danone wanted the business.<\/p>\n \u201cDanone doesn\u2019t need another yogurt brand, or protein drink. They need a digital-native customer acquisition machine,\u201d says Karl Bickley, a former Glanbia and FrieslandCampina executive and founder of UK-based Seventy8 Consulting. \u201cHuel\u2019s direct-to-consumer model, its subscription architecture, its community engagement \u2013 that\u2019s what a multi-billion company like Danone can\u2019t build internally without taking five years and a fortune but, in this case, it also brings a retail successful business at the same time.\u201d<\/p>\n The track-record of major CPG businesses buying direct-to-consumer outfits is not spotless. Foodspring ceased trading last June six years after Mars acquired a majority stake in the German sports-nutrition firm.<\/p>\n Richard Wyborn, a partner at European consultancy Food Strategy Associates, also points to an announcement that came two months later when it emerged Ireland\u2019s Glanbia was selling the online Body & Fit sports-nutrition business it had bought in 2017.<\/p>\n \u201cOne area highlighted by Danone \u2013 leveraging Huel\u2019s DTC capabilities \u2013 warrants scepticism. Large corporates have historically struggled to integrate and fully capitalise on DTC models and the track record across the industry is mixed at best: Mars\/Foodspring; Glanbia\/Body and Fit). There is little to suggest this case will be markedly different,\u201d Wyborn tells Just Food<\/em>.<\/p>\n He points to the potential benefits ahead for Huel of having Danone as its owner \u2013 retail distribution. \u201cThe product is already performing strongly and Danone\u2019s distribution capabilities should enable significant expansion \u2013 both within existing markets and into new geographies. There are also clear opportunities for synergies in R&D, particularly given Huel\u2019s positioning around complete nutrition.\u201d<\/p>\n The \u2013 reported – \u20ac1bn price tag will also be a talking point. The most recent publicly available numbers for Huel are now dated, covering the 12 months to the end of July 2024<\/em>. However, the company gave Just Food<\/em> a flavour of its figures for the following year, indicating revenue reached at least \u00a3250m, with an EBITDA margin of around 10%.<\/p>\n \u201cWhile the strategic rationale is compelling, the valuation cannot be overlooked,\u201d Wyborn says. \u201cDanone has paid a substantial multiple and, despite the clear upside potential, there remain legitimate questions about whether the investment will ultimately deliver the expected returns.\u201d<\/p>\n Ackerman says Barclays\u2019 assumption is that Huel\u2019s fiscal year 2026 sales will reach around \u00a3300m, which, with a 13% EBITDA margin, would see the company generate around \u00a340m of EBITDA.<\/p>\n Those numbers would mean \u201ca purchase multiple of 22 times EBITDA based on the reported acquisition value of \u20ac1bn\u201d, he notes.<\/p>\n \u201cThis valuation multiple is quite high versus peers,\u201d Ackerman adds. \u201cHowever, this is easier to justify for an asset with strong growth, attractive category exposure and clear international runway.\u201d<\/p>\n Di Napoli is also sanguine. \u201cWhile Huel\u2019s current EBITDA margin (around 8.5%) would be dilutive in the short term, its high gross margin provides clear upside. Combined with Danone\u2019s scale and operational capabilities, there is a credible path to 15%-plus EBITDA margins within three to five years.\u201d<\/p>\n “Danone makes logical \u2013 but pricey \u2013 protein push with Huel deal” was originally created and published by Just Food, a GlobalData owned brand.<\/p>\n \u00a0<\/p>\n
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.<\/small><\/i><\/p>\n<\/p><\/div>\n